Tag: inhalation solution

Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1Pivotal Phase 3 CYPRESS study enrollment on track to complete by late...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsInhalation solution

Solventum Announces Launch of Secondary Offering of Common Stock

Employment BOOST Launches Comprehensive Leadership Coaching Program Integrating 360° Feedback and Industry-Leading Curriculum

The Gross Law Firm Notifies Shareholders of Neogen Corporation(NEOG) of a Class Action Lawsuit and an Upcoming Deadline

Tag: inhalation solution

Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us